meta_pixel
Tapesearch Logo
Log in
This Week in Cardiology

Apr 10 2026 This Week in Cardiology

This Week in Cardiology

Medscape Podcasts

Science, Medicine, Health & Fitness

4.9963 Ratings

🗓️ 10 April 2026

⏱️ 32 minutes

🧾️ Download transcript

Summary

Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I IVUS-Guided PCI

  • OPTIMAL Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600440
  • IVUS-CHIP Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601521
  • ILUMIEN IV Trial https://www.nejm.org/doi/10.1056/NEJMoa2305861
  • DKCRUSH VIII Trial https://doi.org/10.1016/j.jacc.2026.01.081

II Ez-PAVE Trial — Low vs Very Low LDL-targets

Does Ez-PAVE Support 'Lower Is Better' for LDL-C? https://www.medscape.com/viewarticle/does-ez-pave-support-lower-better-ldl-c-2026a1000akx

  • Ez-PAVE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2600283
  • 2026 ACC/AHA Lipid Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423

III CORALreef AddOn

  • CORALreef AddOn Trial https://www.jacc.org/doi/abs/10.1016/j.jacc.2026.03.036
  • This Week in Caardiology 2-6-26 https://www.medscape.com/viewarticle/1003240
  • CORALreef Lipids Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2511002

IV Another Post-MI Beta-blocker Withdrawal Study: SMART-DECISION

  • SMART-DECISION Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2601005
  • ABYSS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0

You're listening to This Week in Cardiology from the heart.org, Medscape Cardiology.

0:05.8

This podcast is intended for health care professionals only.

0:08.8

Any views expressed are the presenters' own and do not necessarily reflect the views of WebMD or Medscape.

0:14.6

When every decision matters, you need trusted medical intelligence.

0:19.0

Medscape AI synthesizes peer-reviewed evidence and Medscape's expert validated content

0:24.0

in seconds, delivering clinically verified answers you can trust.

0:28.3

Join over 13 million Medscape members on the world's leading platform for clinicians.

0:33.7

Start using Medscape AI on the web or in the Medscape app.

0:37.6

Medscape AI, trusted medical intelligence.

0:41.0

Hi, everyone.

0:41.9

This is John Mandrola from the Heart.org Medscape Cardiology,

0:46.1

and this is this week in cardiology for April 10, 2026.

0:50.8

This week, three, imaging-guided PCI trials, two with surprising results,

0:58.6

LDL targets, an oral PSK9 inhibitor, and another beta blocker withdrawal trial.

1:05.8

Let's start with the first Ivis guided PCI trials.

1:10.2

Ivis is intravascular ultrasound. Two trials presented at

1:14.6

ACC, both published in New England Journal of Medicine, failed to find benefit from this Ivis-guided

1:19.9

PCI. The optimal trial studied Ivis in Lefmane disease, and the Ivis CHIP trial enrolled patients with complex high-risk PCI.

1:30.5

I think what's most striking about this story is the enthusiasm for imaging amongst many

1:35.9

proponents who I watch online. You get the sense that imaging is the right thing to do if you are a good

1:42.1

cardiologist. Now, I'm not an interventionalist. I'm an

1:45.9

electrophysiologist, so I approach this from an evidence angle, and oh boy, is there an interesting

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.